1. Home
  2. CLSD vs AAME Comparison

CLSD vs AAME Comparison

Compare CLSD & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • AAME
  • Stock Information
  • Founded
  • CLSD 2011
  • AAME 1968
  • Country
  • CLSD United States
  • AAME United States
  • Employees
  • CLSD N/A
  • AAME N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • AAME Life Insurance
  • Sector
  • CLSD Health Care
  • AAME Finance
  • Exchange
  • CLSD Nasdaq
  • AAME Nasdaq
  • Market Cap
  • CLSD 68.4M
  • AAME 58.9M
  • IPO Year
  • CLSD 2016
  • AAME N/A
  • Fundamental
  • Price
  • CLSD $4.37
  • AAME $2.78
  • Analyst Decision
  • CLSD Hold
  • AAME
  • Analyst Count
  • CLSD 4
  • AAME 0
  • Target Price
  • CLSD $65.00
  • AAME N/A
  • AVG Volume (30 Days)
  • CLSD 78.5K
  • AAME 40.6K
  • Earning Date
  • CLSD 11-11-2025
  • AAME 11-11-2025
  • Dividend Yield
  • CLSD N/A
  • AAME 0.72%
  • EPS Growth
  • CLSD N/A
  • AAME N/A
  • EPS
  • CLSD N/A
  • AAME 0.10
  • Revenue
  • CLSD $4,166,000.00
  • AAME $198,977,000.00
  • Revenue This Year
  • CLSD $98.20
  • AAME N/A
  • Revenue Next Year
  • CLSD $213.77
  • AAME N/A
  • P/E Ratio
  • CLSD N/A
  • AAME $26.54
  • Revenue Growth
  • CLSD N/A
  • AAME 6.98
  • 52 Week Low
  • CLSD $3.32
  • AAME $1.25
  • 52 Week High
  • CLSD $24.75
  • AAME $3.71
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 45.81
  • AAME 32.56
  • Support Level
  • CLSD $4.00
  • AAME $2.73
  • Resistance Level
  • CLSD $4.45
  • AAME $3.15
  • Average True Range (ATR)
  • CLSD 0.40
  • AAME 0.21
  • MACD
  • CLSD 0.13
  • AAME -0.08
  • Stochastic Oscillator
  • CLSD 83.87
  • AAME 27.13

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: